Texas 2023 - 88th Regular

Texas Senate Bill SB2402

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the creation, management, and administration of the Texas Pharmaceutical Initiative.

Companion Bills

TX HB4990

Identical Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.

Previously Filed As

TX HB4990

Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.

TX HB4638

Relating to the Texas Pharmaceutical Initiative.

TX SB2336

Relating to the Texas Pharmaceutical Initiative.

TX HB15

Relating to the creation of the Texas brain university research initiative.

TX SB1652

Relating to the creation, management and administration of the Texas Space Commission and the Texas Aerospace Research and Space Economy Consortium.

TX AB587

State government: pharmaceuticals: procurement: collaborative.

TX HB3613

Relating to pharmaceutical purchasing; prescribing an effective date.

TX HB1688

Health information; creating the Health Care Transparency Initiative Act of 2023; emergency.

TX HB1688

Health information; creating the Health Care Transparency Initiative Act of 2023; emergency.

TX S2492

Relative to pharmaceutical access, costs and transparency

Similar Bills

WI SB737

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

WI AB773

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

WI AB173

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

WI SB203

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

CA SB642

Pharmacy benefit management: Prescription Acquisition and Adjudication Agency.

AR HB1301

To Amend The Prior Authorization Transparency Act.

CA SB650

Cancer Medication Advisory Committee.

TX HB4990

Relating to the Texas Pharmaceutical Initiative and a governing board and advisory council for the initiative.